← Evidence map

ArticleClinical lung cancer2020

QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care.

Tri Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31780402